Key statistics
As of last trade, Molecular Partners AG (MOLN:SWX) traded at 2.98, 10.37% above the 52 week low of 2.70 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.95 |
---|---|
High | 2.99 |
Low | 2.95 |
Bid | 2.95 |
Offer | 2.98 |
Previous close | 2.97 |
Average volume | 12.62k |
---|---|
Shares outstanding | 40.37m |
Free float | 35.38m |
P/E (TTM) | -- |
Market cap | 119.71m CHF |
EPS (TTM) | -1.59 CHF |
Data delayed at least 15 minutes, as of Jul 07 2025 10:41 BST.
More ▼
- Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
- Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025
- Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway
- Molecular Partners to Present at Upcoming Investor Conferences
- Molecular Partners Reports Financial Results and Highlights from Q1 2025
- Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025
- Molecular Partners Announces all Board Proposals Approved at Annual General Meeting
- Molecular Partners to hold three poster presentations at AACR 2025
- Molecular Partners Publishes Invitation to Annual General Meeting 2025
- Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024
More ▼